Finasteride increases anagen hair in men with androgenetic alopecia

D. Van Neste, V. Fuh, P. Sanchez-Pedreno, E. Lopez-Bran, H. Wolff, D. Whiting, J. Roberts, D. Kopera, J. J. Stene, S. Calvieri, Antonella Tosti, E. Prens, M. Guarrera, P. Kanojia, W. He, K. D. Kaufman

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Background. The growth of scalp hair is a cyclical process of successive phases of growth (anagen) and rest (telogen). In previous clinical trials in men with androgenetic alopecia, treatment with finasteride increased scalp hair counts in a defined area (i.e. increased hair density). Objectives. The current study used a phototrichogram methodology to assess the effect of finasteride on the phases of the hair growth cycle. Patients/Methods. Two hundred and twelve men, age 18-40 years, with androgenetic alopecia were randomized to receive finasteride 1 mg daily or placebo for 48 weeks. At baseline and at 24 and 48 weeks, macrophotographs were taken to measure total and anagen hair count in a 1-cm2 target area of the scalp. Results. At baseline, mean total and anagen hair counts in the finasteride group were 200 and 124 hairs, respectively (% anagen = 62%) and the anagen to telogen ratio was 1.74 (geometric mean). In the placebo group, the respective values were 196 and 119 hairs (% anagen = 60%) and 1.57. At week 48, the finasteride group had a net improvement (mean ± SE) compared with placebo in total and anagen hair counts of 17.3 ± 2.5 hairs (8.3% ± 1.4%) and 27.0 ± 2.9 hairs (26% ± 3.1%), respectively (P < 0.001). Furthermore, treatment with finasteride resulted in a net improvement in the anagen to telogen ratio of 47% (P < 0.001). In this study, treatment with finasteride 1 mg day-1 for 48 weeks increased both total and anagen hair counts, and improved the anagen to telogen ratio. Conclusions. These data provide direct evidence that finasteride 1 mg daily promotes the conversion of hairs into the anagen phase. These data support that finasteride treatment results in favourable effects on hair quality that contribute to the visible improvements in hair growth observed in treated patients.

Original languageEnglish
Pages (from-to)804-810
Number of pages7
JournalBritish Journal of Dermatology
Volume143
Issue number4
DOIs
StatePublished - Nov 13 2000
Externally publishedYes

Fingerprint

Finasteride
Alopecia
Hair
Scalp
Placebos
Growth
Therapeutics

Keywords

  • Androgenetic alopecia
  • Finasteride
  • Increased hair growth
  • Phototrichogram
  • Randomized double-blind placebo-controlled clinical trial
  • Scalp hair counts

ASJC Scopus subject areas

  • Dermatology

Cite this

Van Neste, D., Fuh, V., Sanchez-Pedreno, P., Lopez-Bran, E., Wolff, H., Whiting, D., ... Kaufman, K. D. (2000). Finasteride increases anagen hair in men with androgenetic alopecia. British Journal of Dermatology, 143(4), 804-810. https://doi.org/10.1046/j.1365-2133.2000.03780.x

Finasteride increases anagen hair in men with androgenetic alopecia. / Van Neste, D.; Fuh, V.; Sanchez-Pedreno, P.; Lopez-Bran, E.; Wolff, H.; Whiting, D.; Roberts, J.; Kopera, D.; Stene, J. J.; Calvieri, S.; Tosti, Antonella; Prens, E.; Guarrera, M.; Kanojia, P.; He, W.; Kaufman, K. D.

In: British Journal of Dermatology, Vol. 143, No. 4, 13.11.2000, p. 804-810.

Research output: Contribution to journalArticle

Van Neste, D, Fuh, V, Sanchez-Pedreno, P, Lopez-Bran, E, Wolff, H, Whiting, D, Roberts, J, Kopera, D, Stene, JJ, Calvieri, S, Tosti, A, Prens, E, Guarrera, M, Kanojia, P, He, W & Kaufman, KD 2000, 'Finasteride increases anagen hair in men with androgenetic alopecia', British Journal of Dermatology, vol. 143, no. 4, pp. 804-810. https://doi.org/10.1046/j.1365-2133.2000.03780.x
Van Neste D, Fuh V, Sanchez-Pedreno P, Lopez-Bran E, Wolff H, Whiting D et al. Finasteride increases anagen hair in men with androgenetic alopecia. British Journal of Dermatology. 2000 Nov 13;143(4):804-810. https://doi.org/10.1046/j.1365-2133.2000.03780.x
Van Neste, D. ; Fuh, V. ; Sanchez-Pedreno, P. ; Lopez-Bran, E. ; Wolff, H. ; Whiting, D. ; Roberts, J. ; Kopera, D. ; Stene, J. J. ; Calvieri, S. ; Tosti, Antonella ; Prens, E. ; Guarrera, M. ; Kanojia, P. ; He, W. ; Kaufman, K. D. / Finasteride increases anagen hair in men with androgenetic alopecia. In: British Journal of Dermatology. 2000 ; Vol. 143, No. 4. pp. 804-810.
@article{097a613dcfb2442f977f53360375d728,
title = "Finasteride increases anagen hair in men with androgenetic alopecia",
abstract = "Background. The growth of scalp hair is a cyclical process of successive phases of growth (anagen) and rest (telogen). In previous clinical trials in men with androgenetic alopecia, treatment with finasteride increased scalp hair counts in a defined area (i.e. increased hair density). Objectives. The current study used a phototrichogram methodology to assess the effect of finasteride on the phases of the hair growth cycle. Patients/Methods. Two hundred and twelve men, age 18-40 years, with androgenetic alopecia were randomized to receive finasteride 1 mg daily or placebo for 48 weeks. At baseline and at 24 and 48 weeks, macrophotographs were taken to measure total and anagen hair count in a 1-cm2 target area of the scalp. Results. At baseline, mean total and anagen hair counts in the finasteride group were 200 and 124 hairs, respectively ({\%} anagen = 62{\%}) and the anagen to telogen ratio was 1.74 (geometric mean). In the placebo group, the respective values were 196 and 119 hairs ({\%} anagen = 60{\%}) and 1.57. At week 48, the finasteride group had a net improvement (mean ± SE) compared with placebo in total and anagen hair counts of 17.3 ± 2.5 hairs (8.3{\%} ± 1.4{\%}) and 27.0 ± 2.9 hairs (26{\%} ± 3.1{\%}), respectively (P < 0.001). Furthermore, treatment with finasteride resulted in a net improvement in the anagen to telogen ratio of 47{\%} (P < 0.001). In this study, treatment with finasteride 1 mg day-1 for 48 weeks increased both total and anagen hair counts, and improved the anagen to telogen ratio. Conclusions. These data provide direct evidence that finasteride 1 mg daily promotes the conversion of hairs into the anagen phase. These data support that finasteride treatment results in favourable effects on hair quality that contribute to the visible improvements in hair growth observed in treated patients.",
keywords = "Androgenetic alopecia, Finasteride, Increased hair growth, Phototrichogram, Randomized double-blind placebo-controlled clinical trial, Scalp hair counts",
author = "{Van Neste}, D. and V. Fuh and P. Sanchez-Pedreno and E. Lopez-Bran and H. Wolff and D. Whiting and J. Roberts and D. Kopera and Stene, {J. J.} and S. Calvieri and Antonella Tosti and E. Prens and M. Guarrera and P. Kanojia and W. He and Kaufman, {K. D.}",
year = "2000",
month = "11",
day = "13",
doi = "10.1046/j.1365-2133.2000.03780.x",
language = "English",
volume = "143",
pages = "804--810",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Finasteride increases anagen hair in men with androgenetic alopecia

AU - Van Neste, D.

AU - Fuh, V.

AU - Sanchez-Pedreno, P.

AU - Lopez-Bran, E.

AU - Wolff, H.

AU - Whiting, D.

AU - Roberts, J.

AU - Kopera, D.

AU - Stene, J. J.

AU - Calvieri, S.

AU - Tosti, Antonella

AU - Prens, E.

AU - Guarrera, M.

AU - Kanojia, P.

AU - He, W.

AU - Kaufman, K. D.

PY - 2000/11/13

Y1 - 2000/11/13

N2 - Background. The growth of scalp hair is a cyclical process of successive phases of growth (anagen) and rest (telogen). In previous clinical trials in men with androgenetic alopecia, treatment with finasteride increased scalp hair counts in a defined area (i.e. increased hair density). Objectives. The current study used a phototrichogram methodology to assess the effect of finasteride on the phases of the hair growth cycle. Patients/Methods. Two hundred and twelve men, age 18-40 years, with androgenetic alopecia were randomized to receive finasteride 1 mg daily or placebo for 48 weeks. At baseline and at 24 and 48 weeks, macrophotographs were taken to measure total and anagen hair count in a 1-cm2 target area of the scalp. Results. At baseline, mean total and anagen hair counts in the finasteride group were 200 and 124 hairs, respectively (% anagen = 62%) and the anagen to telogen ratio was 1.74 (geometric mean). In the placebo group, the respective values were 196 and 119 hairs (% anagen = 60%) and 1.57. At week 48, the finasteride group had a net improvement (mean ± SE) compared with placebo in total and anagen hair counts of 17.3 ± 2.5 hairs (8.3% ± 1.4%) and 27.0 ± 2.9 hairs (26% ± 3.1%), respectively (P < 0.001). Furthermore, treatment with finasteride resulted in a net improvement in the anagen to telogen ratio of 47% (P < 0.001). In this study, treatment with finasteride 1 mg day-1 for 48 weeks increased both total and anagen hair counts, and improved the anagen to telogen ratio. Conclusions. These data provide direct evidence that finasteride 1 mg daily promotes the conversion of hairs into the anagen phase. These data support that finasteride treatment results in favourable effects on hair quality that contribute to the visible improvements in hair growth observed in treated patients.

AB - Background. The growth of scalp hair is a cyclical process of successive phases of growth (anagen) and rest (telogen). In previous clinical trials in men with androgenetic alopecia, treatment with finasteride increased scalp hair counts in a defined area (i.e. increased hair density). Objectives. The current study used a phototrichogram methodology to assess the effect of finasteride on the phases of the hair growth cycle. Patients/Methods. Two hundred and twelve men, age 18-40 years, with androgenetic alopecia were randomized to receive finasteride 1 mg daily or placebo for 48 weeks. At baseline and at 24 and 48 weeks, macrophotographs were taken to measure total and anagen hair count in a 1-cm2 target area of the scalp. Results. At baseline, mean total and anagen hair counts in the finasteride group were 200 and 124 hairs, respectively (% anagen = 62%) and the anagen to telogen ratio was 1.74 (geometric mean). In the placebo group, the respective values were 196 and 119 hairs (% anagen = 60%) and 1.57. At week 48, the finasteride group had a net improvement (mean ± SE) compared with placebo in total and anagen hair counts of 17.3 ± 2.5 hairs (8.3% ± 1.4%) and 27.0 ± 2.9 hairs (26% ± 3.1%), respectively (P < 0.001). Furthermore, treatment with finasteride resulted in a net improvement in the anagen to telogen ratio of 47% (P < 0.001). In this study, treatment with finasteride 1 mg day-1 for 48 weeks increased both total and anagen hair counts, and improved the anagen to telogen ratio. Conclusions. These data provide direct evidence that finasteride 1 mg daily promotes the conversion of hairs into the anagen phase. These data support that finasteride treatment results in favourable effects on hair quality that contribute to the visible improvements in hair growth observed in treated patients.

KW - Androgenetic alopecia

KW - Finasteride

KW - Increased hair growth

KW - Phototrichogram

KW - Randomized double-blind placebo-controlled clinical trial

KW - Scalp hair counts

UR - http://www.scopus.com/inward/record.url?scp=0033751660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033751660&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2133.2000.03780.x

DO - 10.1046/j.1365-2133.2000.03780.x

M3 - Article

C2 - 11069460

AN - SCOPUS:0033751660

VL - 143

SP - 804

EP - 810

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 4

ER -